...
  • 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>The Chinese-German Journal of Clinical Oncology >Therapeutic Effect of Transcatheter Arterial Chemoembolization Combined with Percutaneous Ethanol Injection in Hepatocellular Carcinoma
【24h】

Therapeutic Effect of Transcatheter Arterial Chemoembolization Combined with Percutaneous Ethanol Injection in Hepatocellular Carcinoma

机译：经导管动脉化疗栓塞联合经皮乙醇注射液治疗肝癌的疗效观察

获取原文
获取原文并翻译 | 示例
           
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

Objective To evaluate the clinical efficacy of the combined treatment with transcatheter arterial chemoembolization (TACE) and percutaneous ethanol injection (PEI) on hepatocellular carcinoma (HCC) . Methods 312 patients with moderate or advanced HCCs were divided into two groups: 170 cases underwent TACE treatment alone, 142 cases were treated with TACE and PEI under B-ultrasound guidance. Results The rates of reduction in tumor diameter and the decline in serum AFP level were 41.2% and 40.4% in the TACE group and 75.4% and 74.1 % in the TACE + PEI group respectively. The 6, 12 and 24 months survival rates in the TACE group were 77.1 % , , 34.1% and 18.8% .respectively and in the TACE + PEI group 87.3% , 62.0% and 38.0% , respectively. Overall, there was a significant difference between the two treatment groups ( P < 0.05). Conclusion Treatment on HCCs with TACE + PEI is convenient, safe and results in better survival rates than TACE alone.
机译：目的评价经导管动脉化疗栓塞（TACE）和经皮乙醇注射液（PEI）联合治疗肝癌（HCC）的临床疗效。方法将312例中度或晚期HCC患者分为两组：170例仅接受TACE治疗，142例接受TACE和PEI联合B超检查。结果TACE组肿瘤直径缩小率和血清AFP水平下降率分别为41.2％和40.4％，TACE + PEI组分别为75.4％和74.1％。 TACE组的6、12和24个月生存率分别为77.1％，34.1％和18.8％，TACE + PEI组分别为87.3％，62.0％和38.0％。总体而言，两个治疗组之间存在显着差异（P <0.05）。结论与单独使用TACE相比，使用TACE + PEI治疗HCC方便，安全且可提高生存率。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号